Sutro Biopharma terminates ATM equity program, reports 2025 financial results

Filed March 23, 2026 · Period ending March 23, 2026 · ~1 min read

Key Changes

• medium

  Sutro and Jefferies mutually terminated the at-the-market equity offering agreement effective March 23, 2026. The company can no longer issue additional shares under this facility, which had been in place since April 2021.

  Item 1.02 verify on EDGAR →
• medium

  The company announced full-year 2025 financial results via press release on March 23, 2026. Actual financial figures and performance metrics are contained in the attached press release, not in the 8-K body.

  Item 2.02 verify on EDGAR →